Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Nuwellis Inc(NUWE)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NUWE
09/24/2026: NUWE (1-star) is currently NOT-A-BUY. Pass it for now.
Nuwellis Inc is a small-cap medical device company specializing in fluid management technology, particularly its Aquadex SmartFlow system used for treating fluid overload in acute care settings. The company’s primary growth story centers on increasing hospital adoption of its proprietary ultrafiltration technology as an alternative to traditional diuretic medication. However, Nuwellis faces intense competition from established, large-cap medical device manufacturers and risks associated with limited cash reserves and operational execution. The stock is best suited for investors with a very high risk tolerance who are looking for speculative exposure to the medical technology sector. Key developments to monitor include revenue growth milestones and any strategic partnerships that could provide capital or commercial scale.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company's small scale and inconsistent growth profile make it a high-risk venture for typical growth investors. |
| Momentum investor | Weak fit | The stock lacks the consistent trend and volume strength required for a momentum strategy. |
| Value investor | Weak fit | Current financial losses and negative equity values render traditional value metrics inapplicable. |
| Dividend investor | Weak fit | The company does not pay dividends and focuses on cash preservation. |
| Low-risk investor | Weak fit | High volatility and operational risks are generally unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is subject to significant price swings due to low float and clinical outcome uncertainty. |
| Valuation risk | High | Valuation is often disconnected from fundamentals, driven by speculative market sentiment. |
| Competition risk (Medical Devices) | High | The company competes with dominant firms that possess larger sales forces and deeper hospital ties. |
| Business quality | Medium | While the technology is innovative, the underlying business franchise is still unproven at scale. |
| Dividend income | Low / none | No income potential exists for investors seeking dividends. |
| Execution risk | High | Failure to achieve widespread physician and hospital adoption would significantly threaten the company's future. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -47.73% | Avg. Invested days 5 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/24/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.70M USD | Price to earnings Ratio - | 1Y Target Price 11 |
Price to earnings Ratio - | 1Y Target Price 11 | ||
Volume (30-day avg) 3.2M shares | Beta 0.23 | 52 Weeks Range 0.71 - 172.90 | Updated Date 09/24/2026 |
52 Weeks Range 0.71 - 172.90 | Updated Date 09/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2586.7 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Fluid Management Systems | Aquadex SmartFlow consoles and associated disposable sets. | The company generates revenue primarily by selling medical hardware and the recurring disposable supplies used with that hardware. |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -1.08M | Price to Sales(TTM) 0.3 |
Enterprise Value -1.08M | Price to Sales(TTM) 0.3 | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -0.34 | Shares Outstanding 3.18M | Shares Floating 3.45M |
Shares Outstanding 3.18M | Shares Floating 3.45M | ||
Percent Insiders 4.96 | Percent Institutions 2.59 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Nuwellis Inc
Exchange NASDAQ | Headquarters Eden Prairie, MN, United States | ||
IPO Launch date 2012-02-16 | President, CEO & Director Mr. Michael Kendrick McCormick | ||
Sector Healthcare | Industry Medical Devices | Full time employees 38 | Website https://www.nuwellis.com |
Full time employees 38 | Website https://www.nuwellis.com | ||
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.